Production of phenylalanine-reduced soymilk for phenylketonuria patients

dc.authorid0000000201950070tr
dc.contributor.authorGölge, Evren
dc.contributor.authorTaşdemir, Yasemin
dc.date.accessioned2024-03-08T11:44:42Z
dc.date.available2024-03-08T11:44:42Z
dc.date.issued2023tr
dc.departmentMühendislik Fakültesitr
dc.description.abstractPhenylketonuria (PKU) is a hereditary disease caused by the deficiency of phenylalanine (Phe) hydroxylase enzyme or its cofactor tetrahydrobiopterin. Treatment involves a Phe-restricted diet, although food options are limited. Soymilk, derived from soybeans, is a functional food with nutritional benefits. In this study, soymilk was produced and hydrolyzed with protease of Aspergillus oryzae and papain, and then activated carbon was used to remove Phe for PKU patients. The second-derivative spectrophotometry method was used to determine Phe content in soymilk. The results showed no significant difference in dry matter, fat, and crude fiber between soymilk and Phe-extracted soymilk with respect to the control group (P < 0.05). Soymilk’s protein content was calculated as 2.74% (w/w) and that of Phe-reduced soymilk as 1.94% (w/w). Similarly, consecutive Phe content was 40.53 mg/L and 5.09 mg/L. After hydrolization, the calculated Phe removal rate was 87.44% (w/w), and the protein content was reduced by 29.19% (w/w). The study demonstrates that Phe-reduced soymilk is suitable for PKU patients, thus reducing the need for imported products and offering new market opportunities.tr
dc.identifier.doi10.15586/qas.v15i4.1396en_US
dc.identifier.endpage189tr
dc.identifier.issue4tr
dc.identifier.scopus2-s2.0-85182987652en_US
dc.identifier.scopusqualityN/A
dc.identifier.startpage179tr
dc.identifier.urihttps://hdl.handle.net/20.500.12418/15080
dc.identifier.volume15tr
dc.identifier.wosWOS:001133692400001en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherCodon Publishing Co.tr
dc.relation.ispartofQuality Assurance and Safety of Crops & Foodsen_US
dc.relation.publicationcategoryUluslararası Editör Denetimli Dergide Makaletr
dc.rightsinfo:eu-repo/semantics/openAccesstr
dc.subjectphenylketonuria; soymilk; phenylalanine; activated carbontr
dc.titleProduction of phenylalanine-reduced soymilk for phenylketonuria patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
2023_Tasdemir Gölge_Production of Phenylalanine Reduced Soymilk for Phenylketonuria Patients.pdf
Boyut:
722.25 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: